E-LIB Suche - Ergebnisse für: Marta, G. Nader

1

Adjuvant chemotherapy with or without atezolizumab for stag..:

McArthur, H. ; Bailey, A. ; Saji, S....
European Journal of Cancer. 200 (2024) - p. 113952 , 2024

Link: https://doi.org/10.1016/..

2

64P Baseline characteristics associated with Ki67 drop afte..:

Branco, D. Martins ; Molinelli, C. ; Marta, G. Nader...
ESMO Open. 8 (2023) 1 - p. 101288 , 2023

Link: https://doi.org/10.1016/..

3

26P ctDNA prognostic and diagnostic value for recurrence in..:

Marta, G. Nader ; Monforte, M. ; Cinquini, M....
ESMO Open. 8 (2023) 1 - p. 101250 , 2023

Link: https://doi.org/10.1016/..

4

228P The impact of initial tumor response to docetaxel, tra..:

Debien, V. ; Agostinetto, E. ; Bruzzone, M....
ESMO Open. 8 (2023) 1 - p. 101417 , 2023

Link: https://doi.org/10.1016/..

5

52P Clinical characterization of HER2 low in patients with ..:

Van Baelen, K. ; Nguyen, H.L. ; Richard, F....
ESMO Open. 8 (2023) 1 - p. 101276 , 2023

Link: https://doi.org/10.1016/..

6

Circulating tumor DNA for predicting recurrence in patients..:

Nader-Marta, G. ; Monteforte, M. ; Agostinetto, E....
ESMO Open. 9 (2024) 3 - p. 102390 , 2024

Link: https://doi.org/10.1016/..

7

115P BrainStorm-NSE: Serum neuron-specific enolase as a bio..:

Martins-Branco, D. ; Franzoi, M.A. ; Nader-Marta, G....
ESMO Open. 8 (2023) 1 - p. 101925 , 2023

Link: https://doi.org/10.1016/..

8

Prognostic value of HER2-low status in breast cancer: a sys..:

Molinelli, C. ; Jacobs, F. ; Agostinetto, E....
ESMO Open. 8 (2023) 4 - p. 101592 , 2023

Link: https://doi.org/10.1016/..

9

How we treat patients with metastatic HER2-positive breast ..:

Nader-Marta, G. ; Martins-Branco, D. ; de Azambuja, E.
ESMO Open. 7 (2022) 1 - p. 100343 , 2022

Link: https://doi.org/10.1016/..

10

Efficacy of tyrosine kinase inhibitors for the treatment of..:

Nader-Marta, G. ; Martins-Branco, D. ; Agostinetto, E....
ESMO Open. 7 (2022) 3 - p. 100501 , 2022

Link: https://doi.org/10.1016/..

11

Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibit..:

Becherini, C ; Visani, L ; Caini, S...
ARTN 102586. , 2023

Link: https://repository.icr.a..

12

ESTRO ACROP consensus guideline for target volume delineati..:

Kaidar-Person O ; Vrou Offersen B ; Hol S...
info:eu-repo/semantics/altIdentifier/pmid/31108277. , 2019

Link: http://hdl.handle.net/11..

13

ESTRO consensus guideline for target volume delineation in ..:

Poortmans P ; Verhoeven K ; Tvedskov TF...
http://hdl.handle.net/20.500.11797/imarina5874051. , 2019

Link: https://hdl.handle.net/2..

14

Optimizing Clinical Implementation of Hypofractionation: Co..:

Starling, Maria Thereza Mansur ; Thibodeau, Stephane ; de Sousa, Cecília Félix Penido Mendes...
Cancers. 16 (2024) 3 - p. 539 , 2024

Link: https://doi.org/10.3390/..

15

Direct costs associated with the management of mucositis: A..:

Rodrigues-Oliveira, Leticia ; Kowalski, Luiz Paulo ; Santos, Marcos...
Oral Oncology. 118 (2021) - p. 105296 , 2021

Link: https://doi.org/10.1016/..